**About the Editor**

**Max Cr ¨usemann** is currently a Junior Research Group Leader in the Institute of Pharmaceutical Biology, University of Bonn. He studied Pharmacy at the University of Marburg, and obtained his Ph.D. from the University of Bonn for biosynthetic studies on a complex bacterial natural product (advisor Prof. Jorn Piel). After post-doctoral training on bacterial natural product genomics and ¨ metabolomics in the group of Prof. Bradley Moore at the Scripps Institution of Oceanography, San Diego, he returned to Bonn to Prof. Gabriele Konig's group and started his independent career in ¨ 2017. He and his group are interested in omics-guided discovery and biosynthetic studies of bacterial natural products.
